Stada Poised To Launch As Calliditas Finally Wins EU Nod For Kinpeygo
Stada To Commercialize In EU
The Swedish biotech’s patience paid off as it received a positive EU CHMP opinion on its rare nephrology drug Kinpeygo, known elsewhere as Tarpeyo, following delays related to manufacturing questions.
